Two Seas Capital LP

Holdings History for Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Symbol: ABUS on Nasdaq
Investment type: Equity / Common Shares, without par value
Latest Disclosed Shares Owned: 12,589,158 shares
Security Ownership %: 6.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Two Seas Capital LP ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS)

17 Feb 2026 - Two Seas Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,589,158 shares of Arbutus Biopharma Corp Common Shares, without par value (ABUS). This represents 6.5% ownership of the company. In their previous filing dated 13 Aug 2025, Two Seas Capital LP had reported owning 10,443,317 shares, indicating an increase of +21%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Two Seas Capital LP	6.5%	+22%	$59,672,609	12,589,158	+2,145,841	+21%	$4.74	13G/A	31 Dec 2025	17 Feb 2026, 16:21
Two Seas Capital LP	5.4%		$33,836,347	10,443,317			$3.24	13G	30 Jun 2025	13 Aug 2025, 17:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	3.5%	+0.45%	$60,553,850	12,589,158	+1,597,897	+15%	$4.81	Q4 2025
30 Sep 2025	3%	+0.15%	$49,900,325	10,991,261	+547,944	+5.2%	$4.54	Q3 2025
30 Jun 2025	3.2%	+0.3%	$32,269,850	10,443,317	+977,361	+10%	$3.09	Q2 2025
31 Mar 2025	5.1%	+0.39%	$33,036,186	9,465,956	+725,000		$3.49	Q1 2025
31 Dec 2024	3.4%	+0.14%	$28,582,926	8,740,956	+353,568	+4.2%	$3.27	Q4 2024
30 Sep 2024	5.5%	-0.12%	$32,291,444	8,387,388	-184,363	-2.2%	$3.85	Q3 2024
30 Jun 2024	4.3%	+0.44%	$26,486,711	8,571,751	+729,824	+9.3%	$3.09	Q2 2024
31 Mar 2024	4%	-0.61%	$20,232,172	7,841,927	-1,200,000	-13%	$2.58	Q1 2024
31 Dec 2023	5.6%	+0.47%	$22,604,818	9,041,927	+761,109	+9.2%	$2.50	Q4 2023
30 Sep 2023	3.4%	0%	$16,810,061	8,280,818	0		$2.03	Q3 2023
30 Jun 2023	4.2%	+0.41%	$19,045,881	8,280,818	+816,094	+11%	$2.30	Q2 2023
31 Mar 2023	21%	-0.11%	$22,618,114	7,464,724	-39,469	-0.53%	$3.03	Q1 2023
31 Dec 2022	17%	+4.1%	$17,484,770	7,504,193	+1,850,276	+33%	$2.33	Q4 2022
30 Sep 2022	12%	0%	$10,799,000	5,653,917	0		$1.91	Q3 2022
30 Jun 2022		0%	$9,490,000	3,501,876	0		$2.71 ^*	Q2 2022
31 Mar 2022	5.5%	+3.4%	$6,553,000	2,199,069	+1,373,500	+166%	$2.98	Q1 2022
31 Dec 2021	2.5%	0%	$3,211,000	825,569	0		$3.89	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.